Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.428, 2003-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Enfuvirtide: cost and QOL effect in HIV infections
Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. :
Access to resources
Recommend
QOL in HIV infections enhanced with 12 months of HAART
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 400, 2003-01 ,pp. :
Enfuvirtide: the first HIV fusion inhibitor
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 3, 2005-03 ,pp. :
Enfuvirtide in HIV-1: beneficial but expensive
Inpharma, Vol. 1, Iss. 1390, 2003-01 ,pp. :
Drugs, Vol. 63, Iss. 24, 2003-01 ,pp. :